Nls pharmaceutics to participate in the healthcare virtual conference presented by maxim group llc and hosted by m-vest

Zurich, switzerland / accesswire / june 15, 2023 / nls pharmaceutics ltd. (nasdaq:nlsp, nlspw) ("nls" or the "company"), a swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that alex zwyer, chief executive officer of nls pharmaceutics will present at the healthcare virtual conference part ii, presented by maxim group llc and hosted by m-vest on wednesday, june 20, 2023 at 10:30 am et.
NLSP Ratings Summary
NLSP Quant Ranking